{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:31:20Z","timestamp":1792621880980,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Dis Primers"],"DOI":"10.1038\/s41572-025-00622-5","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:02:11Z","timestamp":1748502131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Brugada syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Bharat","family":"Narasimhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-7493","authenticated-orcid":false,"given":"Jonathan","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-2254","authenticated-orcid":false,"given":"Michelle M.","family":"Monasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Miyasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3172-6106","authenticated-orcid":false,"given":"Pedro","family":"Brugada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayakrit","family":"Krittanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"622_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","volume":"20","author":"P Brugada","year":"1992","unstructured":"Brugada, P. & Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20, 1391\u20131396 (1992). The original and earliest description of BrS.","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","volume":"7","author":"JD Kapplinger","year":"2010","unstructured":"Kapplinger, J. D. et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 7, 33\u201346 (2010).","journal-title":"Heart Rhythm"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jacc.2018.06.037","volume":"72","author":"J Brugada","year":"2018","unstructured":"Brugada, J., Campuzano, O., Arbelo, E., Sarquella-Brugada, G. & Brugada, R. Present status of Brugada syndrome. J. Am. Coll. Cardiol. 72, 1046\u20131059 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR4","first-page":"1389","volume":"15","author":"SG Priori","year":"2013","unstructured":"Priori, S. G. et al. Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. EP Eur. 15, 1389\u20131406 (2013).","journal-title":"EP Eur."},{"key":"622_CR5","first-page":"267","volume":"34","author":"W Vutthikraivit","year":"2018","unstructured":"Vutthikraivit, W. et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis. Acta Cardiol. Sin. 34, 267\u2013277 (2018). A meta-analysis outlining the geographical variations in the prevalence of BrS.","journal-title":"Acta Cardiol. Sin."},{"key":"622_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005643","volume":"95","author":"XQ Quan","year":"2016","unstructured":"Quan, X. Q. et al. A meta-analytic review of prevalence for Brugada ECG patterns and the risk for death. Medicine 95, e5643 (2016).","journal-title":"Medicine"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0002-9149(97)00113-6","volume":"79","author":"K Nademanee","year":"1997","unstructured":"Nademanee, K. Sudden unexplained death syndrome in Southeast Asia. Am. J. Cardiol. 79, 10\u201311 (1997).","journal-title":"Am. J. Cardiol."},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.hrthm.2018.01.014","volume":"15","author":"A Milman","year":"2018","unstructured":"Milman, A. et al. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS). Heart Rhythm 15, 716\u2013724 (2018). A large multicentre international registry profiling clinical events in patients with BrS.","journal-title":"Heart Rhythm"},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/CIRCULATIONAHA.106.664219","volume":"115","author":"V Probst","year":"2007","unstructured":"Probst, V. et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 115, 2042\u20132048 (2007).","journal-title":"Circulation"},{"key":"622_CR10","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1046\/j.1460-9592.2003.t01-1-00227.x","volume":"26","author":"K Matsuo","year":"2003","unstructured":"Matsuo, K., Akahoshi, M., Seto, S. & Yano, K. Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance? Pacing Clin. Electrophysiol. 26, 1551\u20131553 (2003).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jelectrocard.2018.11.011","volume":"52","author":"G Yang","year":"2019","unstructured":"Yang, G. et al. Lack of influence of sex hormones on Brugada syndrome-associated mutant NaV1.5 sodium channel. J. Electrocardiol. 52, 82\u201387 (2019).","journal-title":"J. Electrocardiol."},{"key":"622_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005222","volume":"10","author":"A Milman","year":"2017","unstructured":"Milman, A. et al. Age of first arrhythmic event in Brugada syndrome: data from the SABRUS (Survey on Arrhythmic Events in Brugada Syndrome) in 678 patients. Circ. Arrhythm. Electrophysiol. 10, e005222 (2017).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1469-1809.2009.00517.x","volume":"73","author":"H Li","year":"2009","unstructured":"Li, H. et al. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Ann. Hum. Genet. 73, 335\u2013345 (2009).","journal-title":"Ann. Hum. Genet."},{"key":"622_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12823","volume":"26","author":"D Zhao","year":"2021","unstructured":"Zhao, D. et al. Long-term follow-up in patients with Brugada syndrome in South China. Ann. Noninvasive Electrocardiol. 26, e12823 (2021).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jacc.2012.04.037","volume":"60","author":"L Crotti","year":"2012","unstructured":"Crotti, L. et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J. Am. Coll. Cardiol. 60, 1410\u20131418 (2012). This paper stratified patients by ethnicity to assess the prevalence and clinical implications of different BrS-related mutations.","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jelectrocard.2004.01.007","volume":"37","author":"MH Huang","year":"2004","unstructured":"Huang, M. H. & Marcus, F. I. Idiopathic Brugada-type electrocardiographic pattern in an octogenarian. J. Electrocardiol. 37, 109\u2013111 (2004).","journal-title":"J. Electrocardiol."},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.hrthm.2019.07.003","volume":"16","author":"A Milman","year":"2019","unstructured":"Milman, A. et al. Ethnic differences in patients with Brugada syndrome and arrhythmic events: new insights from survey on arrhythmic events in Brugada syndrome. Heart Rhythm 16, 1468\u20131474 (2019).","journal-title":"Heart Rhythm"},{"key":"622_CR18","first-page":"1287","volume":"22","author":"PS Huang","year":"2020","unstructured":"Huang, P. S. et al. Prevalence of sudden arrhythmic death syndrome-related genetic mutations in an asian cohort of whole genome sequence. EP Eur. 22, 1287\u20131297 (2020).","journal-title":"EP Eur."},{"key":"622_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.105.580811","volume":"113","author":"CR Bezzina","year":"2006","unstructured":"Bezzina, C. R. et al. Common sodium channel promoter haplotype in asian subjects underlies variability in cardiac conduction. Circulation 113, 338\u2013344 (2006).","journal-title":"Circulation"},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1086\/521201","volume":"81","author":"H Li","year":"2007","unstructured":"Li, H. et al. Geographically separate increases in the frequency of the derived ADH1B*47His allele in Eastern and Western Asia. Am. J. Hum. Genet. 81, 842\u2013846 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"622_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/joa3.12227","volume":"35","author":"Q Wu","year":"2019","unstructured":"Wu, Q. et al. Genetic variants of alcohol\u2010metabolizing enzymes in Brugada syndrome: insights into syncope after drinking alcohol. J. Arrhythm. 35, 547\u2013554 (2019).","journal-title":"J. Arrhythm."},{"key":"622_CR22","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/01.WNL.0000142971.08275.DB","volume":"63","author":"Y Suzuki","year":"2004","unstructured":"Suzuki, Y. et al. Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae. Neurology 63, 1711\u20131713 (2004).","journal-title":"Neurology"},{"key":"622_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-13-6260-6_1","volume":"1193","author":"MM El-Mas","year":"2019","unstructured":"El-Mas, M. M. & Abdel-Rahman, A. A. Role of alcohol oxidative metabolism in its cardiovascular and autonomic effects. Adv. Exp. Med. Biol. 1193, 1\u201333 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"622_CR24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.hrthm.2018.04.007","volume":"15","author":"Y Michowitz","year":"2018","unstructured":"Michowitz, Y. et al. Fever-related arrhythmic events in the multicenter survey on arrhythmic events in Brugada syndrome. Heart Rhythm 15, 1394\u20131401 (2018).","journal-title":"Heart Rhythm"},{"key":"622_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.yjmcc.2010.07.012","volume":"49","author":"AAM Wilde","year":"2010","unstructured":"Wilde, A. A. M. et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J. Mol. Cell Cardiol. 49, 543\u2013553 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"622_CR26","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","volume":"100","author":"GX Yan","year":"1999","unstructured":"Yan, G. X. & Antzelevitch, C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100, 1660\u20131666 (1999).","journal-title":"Circulation"},{"key":"622_CR27","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1161\/CIRCULATIONAHA.105.532614","volume":"112","author":"R Coronel","year":"2005","unstructured":"Coronel, R. et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112, 2769\u20132777 (2005).","journal-title":"Circulation"},{"key":"622_CR28","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1161\/CIRCULATIONAHA.122.061924","volume":"147","author":"C Miles","year":"2023","unstructured":"Miles, C. et al. Subepicardial cardiomyopathy: a disease underlying J-wave syndromes and idiopathic ventricular fibrillation. Circulation 147, 1622\u20131633 (2023).","journal-title":"Circulation"},{"key":"622_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/eurheartj\/ehaa1051","volume":"42","author":"ER Behr","year":"2021","unstructured":"Behr, E. R., Ben-Haim, Y., Ackerman, M. J., Krahn, A. D. & Wilde, A. A. M. Brugada syndrome and reduced right ventricular outflow tract conduction reserve: a final common pathway? Eur. Heart J. 42, 1073\u20131081 (2021).","journal-title":"Eur. Heart J."},{"key":"622_CR30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/CIRCULATIONAHA.118.035070","volume":"138","author":"SM Hosseini","year":"2018","unstructured":"Hosseini, S. M. et al. Reappraisal of reported genes for sudden arrhythmic death: evidence-based evaluation of gene validity for Brugada syndrome. Circulation 138, 1195\u20131205 (2018). A study re-evaluating the validity of many previously reported genes.","journal-title":"Circulation"},{"key":"622_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41588-021-01007-6","volume":"54","author":"J Barc","year":"2022","unstructured":"Barc, J. et al. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nat. Genet. 54, 232\u2013239 (2022).","journal-title":"Nat. Genet."},{"key":"622_CR32","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.hrthm.2020.06.027","volume":"17","author":"P Makarawate","year":"2020","unstructured":"Makarawate, P. et al. Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand. Heart Rhythm 17, 2145\u20132153 (2020).","journal-title":"Heart Rhythm"},{"key":"622_CR33","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1093\/eurheartj\/ehae480","volume":"45","author":"A Tarantino","year":"2024","unstructured":"Tarantino, A. et al. NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications. Eur. Heart J. 45, 4336\u20134348 (2024).","journal-title":"Eur. Heart J."},{"key":"622_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cell.2019.11.041","volume":"134","author":"D Jiang","year":"2020","unstructured":"Jiang, D. et al. Structure of the cardiac sodium channel. Cell 134, 122\u2013134.e10 (2020).","journal-title":"Cell"},{"key":"622_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","volume":"26","author":"WA Catterall","year":"2000","unstructured":"Catterall, W. A. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26, 13\u201325 (2000).","journal-title":"Neuron"},{"key":"622_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-3-207","volume":"4","author":"FH Yu","year":"2003","unstructured":"Yu, F. H. & Catterall, W. A. Overview of the voltage-gated sodium channel family. Genome Biol. 4, 207 (2003).","journal-title":"Genome Biol."},{"key":"622_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1152\/physrev.1996.76.3.887","volume":"76","author":"HA Fozzard","year":"1996","unstructured":"Fozzard, H. A. & Hanck, D. A. Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol. Rev. 76, 887\u2013926 (1996).","journal-title":"Physiol. Rev."},{"key":"622_CR38","doi-asserted-by":"publisher","first-page":"652027","DOI":"10.3389\/fcvm.2021.652027","volume":"8","author":"MM Monasky","year":"2021","unstructured":"Monasky, M. M., Micaglio, E., Locati, E. T. & Pappone, C. Evaluating the use of genetics in Brugada syndrome risk stratification. Front. Cardiovasc. Med. 8, 652027 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"622_CR39","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/hc1002.105183","volume":"105","author":"CE Clancy","year":"2002","unstructured":"Clancy, C. E. & Rudy, Y. Na+ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 105, 1208\u20131213 (2002).","journal-title":"Circulation"},{"key":"622_CR40","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCULATIONAHA.109.863076","volume":"120","author":"S Kapa","year":"2009","unstructured":"Kapa, S. et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 120, 1752\u20131760 (2009).","journal-title":"Circulation"},{"key":"622_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nrcardio.2013.108","volume":"10","author":"AAM Wilde","year":"2013","unstructured":"Wilde, A. A. M. & Behr, E. R. Genetic testing for inherited cardiac disease. Nat. Rev. Cardiol. 10, 571\u2013583 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"622_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","volume":"4","author":"AAM Wilde","year":"2018","unstructured":"Wilde, A. A. M. & Amin, A. S. Clinical spectrum of SCN5A mutations. JACC Clin. Electrophysiol. 4, 569\u2013579 (2018). A detailed overview of SCN5A mutations and their clinical implications.","journal-title":"JACC Clin. Electrophysiol."},{"key":"622_CR43","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","volume":"115","author":"C Antzelevitch","year":"2007","unstructured":"Antzelevitch, C. et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115, 442\u2013449 (2007).","journal-title":"Circulation"},{"key":"622_CR44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3389\/fphys.2018.01088","volume":"9","author":"MM Monasky","year":"2018","unstructured":"Monasky, M. M. et al. Calcium in Brugada syndrome: questions for future research. Front. Physiol. 9, 1088 (2018).","journal-title":"Front. Physiol."},{"key":"622_CR45","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/01.CIR.0000080322.67408.B4","volume":"108","author":"M Valderr\u00e1bano","year":"2003","unstructured":"Valderr\u00e1bano, M., Chen, P. S. & Lin, S. F. Spatial distribution of phase singularities in ventricular fibrillation. Circulation 108, 354\u2013359 (2003).","journal-title":"Circulation"},{"key":"622_CR46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/CIRCULATIONAHA.105.601294","volume":"114","author":"S Poelzing","year":"2006","unstructured":"Poelzing, S. et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 114, 368\u2013376 (2006).","journal-title":"Circulation"},{"key":"622_CR47","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ng.2712","volume":"45","author":"CR Bezzina","year":"2013","unstructured":"Bezzina, C. R. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 45, 1044\u20131049 (2013).","journal-title":"Nat. Genet."},{"key":"622_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jacc.2014.04.032","volume":"64","author":"D Hu","year":"2014","unstructured":"Hu, D. et al. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. J. Am. Coll. Cardiol. 64, 66\u201379 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR49","first-page":"2260","volume":"118","author":"H Watanabe","year":"2008","unstructured":"Watanabe, H. et al. Sodium channel \u03b21 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118, 2260\u20132268 (2008).","journal-title":"J. Clin. Invest."},{"key":"622_CR50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.103.9.1303","volume":"103","author":"DM J","year":"2001","unstructured":"J, D. M. et al. Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes. Circulation 103, 1303\u20131310 (2001).","journal-title":"Circulation"},{"key":"622_CR51","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/humu.22328","volume":"34","author":"H Riur\u00f3","year":"2013","unstructured":"Riur\u00f3, H. et al. A missense mutation in the sodium channel \u03b22 subunit reveals SCN2B as a new candidate gene for Brugada syndrome. Hum. Mutat. 34, 961\u2013966 (2013).","journal-title":"Hum. Mutat."},{"key":"622_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/CIRCGENETICS.108.829192","volume":"2","author":"D Hu","year":"2009","unstructured":"Hu, D. et al. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ. Cardiovasc. Genet. 2, 270\u2013278 (2009).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"622_CR53","doi-asserted-by":"publisher","first-page":"H1446","DOI":"10.1152\/ajpheart.00513.2009","volume":"297","author":"CR Valdivia","year":"2009","unstructured":"Valdivia, C. R., Ueda, K., Ackerman, M. J. & Makielski, J. C. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am. J. Physiol. Heart Circ. Physiol. 297, H1446\u2013H1452 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"622_CR54","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1161\/CIRCULATIONAHA.107.703330","volume":"116","author":"B London","year":"2007","unstructured":"London, B. et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 116, 2260\u20132268 (2007).","journal-title":"Circulation"},{"key":"622_CR55","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.113.003077","volume":"129","author":"M Cerrone","year":"2014","unstructured":"Cerrone, M. et al. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation 129, 1092\u20131103 (2014).","journal-title":"Circulation"},{"key":"622_CR56","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.hrthm.2011.02.021","volume":"8","author":"JR Giudicessi","year":"2011","unstructured":"Giudicessi, J. R. et al. Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 8, 1024\u20131032 (2011).","journal-title":"Heart Rhythm"},{"key":"622_CR57","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/CIRCRESAHA.115.303657","volume":"115","author":"NJ Boczek","year":"2014","unstructured":"Boczek, N. J. et al. Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome. Circ. Res. 115, 460\u2013469 (2014).","journal-title":"Circ. Res."},{"key":"622_CR58","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1253\/circj.CJ-12-0551","volume":"76","author":"T Nakajima","year":"2012","unstructured":"Nakajima, T. et al. KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram. Circ. J. 76, 2763\u20132772 (2012).","journal-title":"Circ. J."},{"key":"622_CR59","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003122","volume":"5","author":"V Portero","year":"2016","unstructured":"Portero, V. et al. Dysfunction of the voltage\u2010gated K+ channel \u03b22 subunit in a familial case of Brugada syndrome. J. Am. Heart Assoc. 5, e003122 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"622_CR60","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.hrthm.2010.06.016","volume":"7","author":"A Medeiros-Domingo","year":"2010","unstructured":"Medeiros-Domingo, A. et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac KATP channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm 7, 1466\u20131471 (2010).","journal-title":"Heart Rhythm"},{"key":"622_CR61","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijcard.2013.12.084","volume":"171","author":"D Hu","year":"2014","unstructured":"Hu, D. et al. ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. Int. J. Cardiol. 171, 431\u2013442 (2014).","journal-title":"Int. J. Cardiol."},{"key":"622_CR62","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/jce.12361","volume":"25","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Gain-of-function KCNH2 mutations in patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 25, 522\u2013530 (2014).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"622_CR63","doi-asserted-by":"publisher","first-page":"100468","DOI":"10.1016\/j.ijcha.2020.100468","volume":"26","author":"KHC Li","year":"2020","unstructured":"Li, K. H. C. et al. Brugada syndrome: a comprehensive review of pathophysiological mechanisms and risk stratification strategies. IJC Heart Vasc. 26, 100468 (2020).","journal-title":"IJC Heart Vasc."},{"key":"622_CR64","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.hrthm.2010.08.026","volume":"7","author":"E Burashnikov","year":"2010","unstructured":"Burashnikov, E. et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 7, 1872\u20131882 (2010).","journal-title":"Heart Rhythm"},{"key":"622_CR65","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.yjmcc.2009.01.014","volume":"46","author":"JM Cordeiro","year":"2009","unstructured":"Cordeiro, J. M. et al. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. J. Mol. Cell Cardiol. 46, 695\u2013703 (2009).","journal-title":"J. Mol. Cell Cardiol."},{"key":"622_CR66","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall, W. A., Perez-Reyes, E., Snutch, T. P. & Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure\u2013function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411\u2013425 (2005).","journal-title":"Pharmacol. Rev."},{"key":"622_CR67","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1124\/jpet.300.3.724","volume":"300","author":"DR Abernethy","year":"2002","unstructured":"Abernethy, D. R. & Soldatov, N. M. Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets. J. Pharmacol. Exp. Ther. 300, 724\u2013728 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"622_CR68","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1253\/circj.CJ-12-1457","volume":"77","author":"M Fukuyama","year":"2013","unstructured":"Fukuyama, M. et al. L-type calcium channel mutations in Japanese patients with inherited arrhythmias. Circ. J. 77, 1799\u20131806 (2013).","journal-title":"Circ. J."},{"key":"622_CR69","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1073\/pnas.1010122108","volume":"108","author":"M Baruscotti","year":"2011","unstructured":"Baruscotti, M. et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene HCN4. Proc. Natl Acad. Sci. USA 108, 1705\u20131710 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"622_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/jhg.2008.16","volume":"54","author":"K Ueda","year":"2009","unstructured":"Ueda, K. et al. Role of HCN4 channel in preventing ventricular arrhythmia. J. Hum. Genet. 54, 115\u2013121 (2009).","journal-title":"J. Hum. Genet."},{"key":"622_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054131","volume":"8","author":"H Liu","year":"2013","unstructured":"Liu, H. et al. Molecular genetics and functional anomalies in a series of 248 Brugada cases with 11 mutations in the TRPM4 channel. PLoS ONE 8, e54131 (2013).","journal-title":"PLoS ONE"},{"key":"622_CR72","doi-asserted-by":"publisher","first-page":"102843","DOI":"10.1016\/j.ebiom.2020.102843","volume":"57","author":"JMJ Juang","year":"2020","unstructured":"Juang, J. M. J. et al. GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with a risk of sudden cardiac death. eBioMedicine 57, 102843 (2020).","journal-title":"eBioMedicine"},{"key":"622_CR73","doi-asserted-by":"crossref","unstructured":"Postema, P. G. et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 6, 1335\u20131341 (2009).","DOI":"10.1016\/j.hrthm.2009.07.002"},{"key":"622_CR74","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjcard.2010.10.046","volume":"107","author":"PG Macedo","year":"2011","unstructured":"Macedo, P. G. et al. Sleep-disordered breathing in patients with the Brugada syndrome. Am. J. Cardiol. 107, 709\u2013713 (2011).","journal-title":"Am. J. Cardiol."},{"key":"622_CR75","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/europace\/eum272","volume":"10","author":"MAB Bigi","year":"2008","unstructured":"Bigi, M. A. B., Aslani, A. & Aslani, A. Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome. Europace 10, 821\u2013824 (2008).","journal-title":"Europace"},{"key":"622_CR76","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.hrthm.2013.07.030","volume":"10","author":"A Adler","year":"2013","unstructured":"Adler, A. et al. Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm 10, 1375\u20131382 (2013).","journal-title":"Heart Rhythm"},{"key":"622_CR77","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCEP.108.816892","volume":"2","author":"S Kamakura","year":"2009","unstructured":"Kamakura, S. et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1\u2013V 3. Circ. Arrhythm. Electrophysiol. 2, 495\u2013503 (2009).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"622_CR78","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.hrthm.2008.08.022","volume":"5","author":"M Takigawa","year":"2008","unstructured":"Takigawa, M. et al. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 5, 1523\u20131527 (2008).","journal-title":"Heart Rhythm"},{"key":"622_CR79","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.hrthm.2008.08.033","volume":"5","author":"PG Postema","year":"2008","unstructured":"Postema, P. G. & Wilde, A. A. M. Arrhythmias in Brugada syndrome: changing throughout day and season? Heart Rhythm 5, 1528\u20131529 (2008).","journal-title":"Heart Rhythm"},{"key":"622_CR80","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jelectrocard.2012.06.004","volume":"45","author":"AB Luna","year":"2012","unstructured":"Luna, A. B. et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J. Electrocardiol. 45, 433\u2013442 (2012).","journal-title":"J. Electrocardiol."},{"key":"622_CR81","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld, K. et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. 43, 3997\u20134126 (2022).","journal-title":"Eur. Heart J."},{"key":"622_CR82","first-page":"665","volume":"19","author":"C Antzelevitch","year":"2017","unstructured":"Antzelevitch, C. et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. Europace 19, 665\u2013694 (2017).","journal-title":"Europace"},{"key":"622_CR83","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.123.064689","volume":"148","author":"F Gaita","year":"2023","unstructured":"Gaita, F. et al. Asymptomatic patients with Brugada ECG pattern: long-term prognosis from a large prospective study. Circulation 148, 1543\u20131555 (2023).","journal-title":"Circulation"},{"key":"622_CR84","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1093\/eurheartj\/ehl205","volume":"27","author":"C Veltmann","year":"2006","unstructured":"Veltmann, C. et al. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur. Heart J. 27, 2544\u20132552 (2006).","journal-title":"Eur. Heart J."},{"key":"622_CR85","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","volume":"111","author":"C Antzelevitch","year":"2005","unstructured":"Antzelevitch, C. et al. Brugada syndrome: report of the second consensus conference: endorsed by the heart rhythm society and the European heart rhythm association. Circulation 111, 659\u2013670 (2005).","journal-title":"Circulation"},{"key":"622_CR86","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amjcard.2014.10.007","volume":"115","author":"N Cerrato","year":"2015","unstructured":"Cerrato, N. et al. Prevalence of type 1 Brugada electrocardiographic pattern evaluated by twelve-lead twenty-four-hour holter monitoring. Am. J. Cardiol. 115, 52\u201356 (2015).","journal-title":"Am. J. Cardiol."},{"key":"622_CR87","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/eurheartj\/ehad295","volume":"44","author":"AAM Wilde","year":"2023","unstructured":"Wilde, A. A. M., Amin, A. S., Morita, H. & Tadros, R. Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome. Eur. Heart J. 44, 2427\u20132439 (2023).","journal-title":"Eur. Heart J."},{"key":"622_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4330\/wjc.v6.i3.81","volume":"6","author":"DD Anselm","year":"2014","unstructured":"Anselm, D. D. Brugada phenocopy: a new electrocardiogram phenomenon. World J. Cardiol. 6, 81\u20136 (2014).","journal-title":"World J. Cardiol."},{"key":"622_CR89","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.jacc.2011.08.039","volume":"58","author":"S Chevallier","year":"2011","unstructured":"Chevallier, S. et al. New electrocardiographic criteria for discriminating between Brugada types 2 and 3 patterns and incomplete right bundle branch block. J. Am. Coll. Cardiol. 58, 2290\u20132298 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR90","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/europace\/euu025","volume":"16","author":"G Serra","year":"2014","unstructured":"Serra, G. et al. New electrocardiographic criteria to differentiate the type-2 Brugada pattern from electrocardiogram of healthy athletes with r\u2032-wave in leads V1\/V2. Europace 16, 1639\u20131645 (2014).","journal-title":"Europace"},{"key":"622_CR91","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.joa.2016.07.002","volume":"32","author":"C Antzelevitch","year":"2016","unstructured":"Antzelevitch, C. et al. J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge. J. Arrhythm. 32, 315\u2013339 (2016).","journal-title":"J. Arrhythm."},{"key":"622_CR92","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jacep.2018.02.009","volume":"4","author":"S Kawada","year":"2018","unstructured":"Kawada, S. et al. Shanghai score system for diagnosis of Brugada syndrome: validation of the score system and system and reclassification of the patients. JACC Clin. Electrophysiol. 4, 724\u2013730 (2018).","journal-title":"JACC Clin. Electrophysiol."},{"key":"622_CR93","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/01.CIR.101.5.510","volume":"101","author":"R Brugada","year":"2000","unstructured":"Brugada, R. et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101, 510\u2013515 (2000). Original descriptions of pharmacological provocative testing.","journal-title":"Circulation"},{"key":"622_CR94","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1161\/01.CIR.102.20.2509","volume":"102","author":"SG Priori","year":"2000","unstructured":"Priori, S. G. et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102, 2509\u20132515 (2000).","journal-title":"Circulation"},{"key":"622_CR95","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.hrthm.2014.10.036","volume":"12","author":"D Calvo","year":"2015","unstructured":"Calvo, D. et al. Time-dependent responses to provocative testing with flecainide in the diagnosis of Brugada syndrome. Heart Rhythm 12, 350\u2013357 (2015).","journal-title":"Heart Rhythm"},{"key":"622_CR96","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.hrthm.2013.09.060","volume":"10","author":"G Conte","year":"2013","unstructured":"Conte, G. et al. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis. Heart Rhythm 10, 1869\u20131874 (2013).","journal-title":"Heart Rhythm"},{"key":"622_CR97","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/europace\/euw008","volume":"18","author":"B Dobbels","year":"2016","unstructured":"Dobbels, B., Cleen, D. & Ector, J. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome. Europace 18, 1501\u20131506 (2016).","journal-title":"Europace"},{"key":"622_CR98","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/europace\/euz186","volume":"21","author":"MM Monasky","year":"2019","unstructured":"Monasky, M. M. et al. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants. Europace 21, 1550\u20131558 (2019).","journal-title":"Europace"},{"key":"622_CR99","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.hrthm.2016.01.008","volume":"13","author":"K Kinoshita","year":"2016","unstructured":"Kinoshita, K. et al. SCN5A(K817E), a novel Brugada syndrome\u2013associated mutation that alters the activation gating of NaV1.5 channel. Heart Rhythm 13, 1113\u20131120 (2016).","journal-title":"Heart Rhythm"},{"key":"622_CR100","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1046\/j.1540-8167.2004.03681.x","volume":"15","author":"T Papavassiliu","year":"2004","unstructured":"Papavassiliu, T. et al. Magnetic resonance imaging findings in patients with Brugada syndrome. J. Cardiovasc. Electrophysiol. 15, 1133\u20131138 (2004).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"622_CR101","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1053\/euhj.2000.2424","volume":"22","author":"M Takagi","year":"2001","unstructured":"Takagi, M. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur. Heart J. 22, 1032\u20131041 (2001).","journal-title":"Eur. Heart J."},{"key":"622_CR102","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1536\/ihj.51.17","volume":"51","author":"K Ohkubo","year":"2010","unstructured":"Ohkubo, K. et al. Right ventricular histological substrate and conduction delay in patients with Brugada syndrome. Int. Heart J. 51, 17\u201323 (2010).","journal-title":"Int. Heart J."},{"key":"622_CR103","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.hrthm.2010.09.004","volume":"7","author":"T Papavassiliu","year":"2010","unstructured":"Papavassiliu, T. et al. Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome. Heart Rhythm 7, 1790\u20131796 (2010).","journal-title":"Heart Rhythm"},{"key":"622_CR104","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/eurheartj\/ehaa942","volume":"42","author":"G Ciconte","year":"2021","unstructured":"Ciconte, G. et al. Brugada syndrome genetics is associated with phenotype severity. Eur. Heart J. 42, 1082\u20131090 (2021).","journal-title":"Eur. Heart J."},{"key":"622_CR105","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1161\/hc1102.105288","volume":"105","author":"SG Priori","year":"2002","unstructured":"Priori, S. G. et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105, 1342\u20131347 (2002).","journal-title":"Circulation"},{"key":"622_CR106","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.hrthm.2007.04.017","volume":"4","author":"BB MA","year":"2007","unstructured":"MA, B. B., A, A. & S, S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm 4, 1009\u20131012 (2007).","journal-title":"Heart Rhythm"},{"key":"622_CR107","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.108.770917","volume":"118","author":"H Morita","year":"2008","unstructured":"Morita, H. et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 118, 1697\u20131704 (2008).","journal-title":"Circulation"},{"key":"622_CR108","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1016\/j.hrthm.2015.07.029","volume":"12","author":"P Maury","year":"2015","unstructured":"Maury, P. et al. Increased Tpeak\u2013Tend interval is highly and independently related to arrhythmic events in Brugada syndrome. Heart Rhythm 12, 2469\u20132476 (2015).","journal-title":"Heart Rhythm"},{"key":"622_CR109","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.jacc.2005.12.049","volume":"47","author":"CH J","year":"2006","unstructured":"J, C. H. et al. Tpeak\u2013Tend and Tpeak\u2013Tend dispersion as risk factors for ventricular tachycardia\/ventricular fibrillation in patients with the Brugada syndrome. J. Am. Coll. Cardiol. 47, 1828\u20131834 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR110","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.hrthm.2015.08.038","volume":"13","author":"A Adler","year":"2016","unstructured":"Adler, A. et al. Risk stratification in Brugada syndrome: clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm 13, 299\u2013310 (2016).","journal-title":"Heart Rhythm"},{"key":"622_CR111","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.hrthm.2009.05.007","volume":"6","author":"Z Huang","year":"2009","unstructured":"Huang, Z. et al. Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm 6, 1156\u20131162 (2009).","journal-title":"Heart Rhythm"},{"key":"622_CR112","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0735-1097(02)01962-9","volume":"40","author":"JPP Smits","year":"2002","unstructured":"Smits, J. P. P. et al. Genotype\u2013phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J. Am. Coll. Cardiol. 40, 350\u2013356 (2002).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR113","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12589","volume":"24","author":"P Rattanawong","year":"2019","unstructured":"Rattanawong, P. et al. SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis. Ann. Noninvasive Electrocardiol. 24, e12589 (2019).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"622_CR114","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.amjcard.2013.06.033","volume":"112","author":"P Maury","year":"2013","unstructured":"Maury, P. et al. Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome. Am. J. Cardiol. 112, 1384\u20131389 (2013).","journal-title":"Am. J. Cardiol."},{"key":"622_CR115","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jacc.2016.01.024","volume":"67","author":"L Cal\u00f2","year":"2016","unstructured":"Cal\u00f2, L. et al. A new electrocardiographic marker of sudden death in Brugada syndrome. J. Am. Coll. Cardiol. 67, 1427\u20131440 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR116","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/eurheartj\/ehx119","volume":"38","author":"J Sieira","year":"2017","unstructured":"Sieira, J. et al. A score model to predict risk of events in patients with Brugada syndrome. Eur. Heart J. 38, 1756\u20131763 (2017).","journal-title":"Eur. Heart J."},{"key":"622_CR117","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","volume":"121","author":"V Probst","year":"2010","unstructured":"Probst, V. et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 121, 635\u2013643 (2010).","journal-title":"Circulation"},{"key":"622_CR118","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","volume":"133","author":"J Sroubek","year":"2016","unstructured":"Sroubek, J., Probst, V. & Mazzanti, A. Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis. Circulation 133, 622\u2013630 (2016).","journal-title":"Circulation"},{"key":"622_CR119","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.hrthm.2011.09.053","volume":"9","author":"H Makimoto","year":"2012","unstructured":"Makimoto, H. et al. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram. Heart Rhythm 9, 242\u2013248 (2012).","journal-title":"Heart Rhythm"},{"key":"622_CR120","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jacc.2018.02.022","volume":"71","author":"C Pappone","year":"2018","unstructured":"Pappone, C. et al. Assessing the malignant ventricular arrhythmic substrate in patients with Brugada syndrome. J. Am. Coll. Cardiol. 71, 1631\u20131646 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"622_CR121","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.hrthm.2017.02.026","volume":"14","author":"B Gray","year":"2017","unstructured":"Gray, B. et al. Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications. Heart Rhythm 14, 866\u2013874 (2017).","journal-title":"Heart Rhythm"},{"key":"622_CR122","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jacep.2022.05.003","volume":"8","author":"S Liao","year":"2022","unstructured":"Liao, S. et al. Use of wearable technology and deep learning to improve the diagnosis of Brugada syndrome. JACC Clin. Electrophysiol. 8, 1010\u20131020 (2022).","journal-title":"JACC Clin. Electrophysiol."},{"key":"622_CR123","first-page":"e415","volume":"138","author":"SM Al-Khatib","year":"2017","unstructured":"Al-Khatib, S. M., Stevenson, W. G. & Ackerman, M. J. AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society (published correction appears in Circulation). Circulation 138, e415\u2013e418 (2017).","journal-title":"Circulation"},{"key":"622_CR124","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.3390\/nu13082482","volume":"13","author":"S D\u2019Imperio","year":"2021","unstructured":"D\u2019Imperio, S., Monasky, M. M., Micaglio, E., Negro, G. & Pappone, C. Impact of dietary factors on Brugada syndrome and long QT syndrome. Nutrients 13, 2482 (2021).","journal-title":"Nutrients"},{"key":"622_CR125","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCEP.112.975219","volume":"5","author":"RK Sandhu","year":"2012","unstructured":"Sandhu, R. K. et al. Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ. Arrhythm. Electrophysiol. 5, 1091\u20131097 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"622_CR126","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.007143","volume":"12","author":"A Mazzanti","year":"2019","unstructured":"Mazzanti, A. et al. Efficacy and limitations of quinidine in patients with Brugada syndrome. Circ. Arrhythm. Electrophysiol. 12, e007143 (2019).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"622_CR127","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.hrcr.2017.07.005","volume":"3","author":"J Shenthar","year":"2017","unstructured":"Shenthar, J., Chakali, S. S., Acharya, D., Parvez, J. & Banavalikar, B. Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy. HeartRhythm Case Rep. 3, 470\u2013474 (2017).","journal-title":"HeartRhythm Case Rep."},{"key":"622_CR128","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.hrthm.2007.02.014","volume":"4","author":"T Ohgo","year":"2007","unstructured":"Ohgo, T. et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4, 695\u2013700 (2007).","journal-title":"Heart Rhythm"},{"key":"622_CR129","first-page":"25","volume":"5","author":"P Maury","year":"2005","unstructured":"Maury, P., Hocini, M. & Ha\u00efssaguerre, M. Electrical storms in Brugada syndrome: review of pharmacologic and ablative therapeutic options. Indian Pacing Electrophysiol. J. 5, 25\u201334 (2005).","journal-title":"Indian Pacing Electrophysiol. J."},{"key":"622_CR130","doi-asserted-by":"publisher","first-page":"135","DOI":"10.15420\/aer.2018.21.2","volume":"7","author":"OT Brodie","year":"2018","unstructured":"Brodie, O. T., Michowitz, Y. & Belhassen, B. Pharmacological therapy in Brugada syndrome. Arrhythm. Electrophysiol. Rev. 7, 135\u2013142 (2018).","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"622_CR131","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00392-010-0145-7","volume":"99","author":"PA Schweizer","year":"2010","unstructured":"Schweizer, P. A., Becker, R., Katus, H. A. & Thomas, D. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine\/quinidine. Clin. Res. Cardiol. 99, 467\u2013470 (2010).","journal-title":"Clin. Res. Cardiol."},{"key":"622_CR132","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.hrthm.2024.03.003","volume":"21","author":"E Garc\u00eda-Izquierdo","year":"2024","unstructured":"Garc\u00eda-Izquierdo, E. et al. Arrhythmia detection using an implantable loop recorder after a negative electrophysiology study in Brugada syndrome: observations from a multicenter international registry. Heart Rhythm 21, 1317\u20131324 (2024).","journal-title":"Heart Rhythm"},{"key":"622_CR133","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/eurheartj\/ehae133","volume":"45","author":"M Bergonti","year":"2024","unstructured":"Bergonti, M. et al. Implantable loop recorders in patients with Brugada syndrome: the BruLoop study. Eur. Heart J. 45, 1255\u20131265 (2024).","journal-title":"Eur. Heart J."},{"key":"622_CR134","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.005053","volume":"10","author":"C Pappone","year":"2017","unstructured":"Pappone, C. et al. Electrical substrate elimination in 135 consecutive patients with Brugada syndrome. Circ. Arrhythm. Electrophysiol. 10, e005053 (2017). The largest study evaluating the effectiveness of catheter ablation in BrS.","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"622_CR135","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00392-022-02038-7","volume":"112","author":"Y Kotake","year":"2023","unstructured":"Kotake, Y., Barua, S. & Kazi, S. Efficacy and safety of catheter ablation for Brugada syndrome: an updated systematic review (published correction appears in Clin. Res. Cardiol.). Clin. Res. Cardiol. 112, 853 (2023).","journal-title":"Clin. Res. Cardiol."},{"key":"622_CR136","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCULATIONAHA.122.063367","volume":"147","author":"K Nademanee","year":"2023","unstructured":"Nademanee, K. et al. Long-term outcomes of Brugada substrate ablation: a report from BRAVO (Brugada ablation of VF substrate ongoing multicenter registry). Circulation 147, 1568\u20131578 (2023).","journal-title":"Circulation"},{"key":"622_CR137","doi-asserted-by":"publisher","first-page":"euae019","DOI":"10.1093\/europace\/euae019","volume":"26","author":"V Santinelli","year":"2023","unstructured":"Santinelli, V. et al. High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation. Europace 26, euae019 (2023).","journal-title":"Europace"},{"key":"622_CR138","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15420\/aer.2018.73.2","volume":"8","author":"C Pappone","year":"2019","unstructured":"Pappone, C. & Santinelli, V. Brugada syndrome: progress in diagnosis and management. Arrhythm. Electrophysiol. Rev. 8, 13\u201318 (2019). A review article that provides an update on the diagnosis and management of BrS.","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"622_CR139","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.hrthm.2018.03.019","volume":"15","author":"GC Fernandes","year":"2018","unstructured":"Fernandes, G. C. et al. Ablation strategies for the management of symptomatic Brugada syndrome: a systematic review. Heart Rhythm 15, 1140\u20131147 (2018).","journal-title":"Heart Rhythm"},{"key":"622_CR140","doi-asserted-by":"publisher","first-page":"euad318","DOI":"10.1093\/europace\/euad318","volume":"26","author":"L Li","year":"2023","unstructured":"Li, L. et al. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation. Europace 26, euad318 (2023).","journal-title":"Europace"},{"key":"622_CR141","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jgc4.1075","volume":"28","author":"S Makhnoon","year":"2019","unstructured":"Makhnoon, S., Shirts, B. H. & Bowen, D. J. Patients\u2019 perspectives of variants of uncertain significance and strategies for uncertainty management. J. Genet. Couns. 28, 313\u2013325 (2019).","journal-title":"J. Genet. Couns."},{"key":"622_CR142","doi-asserted-by":"publisher","first-page":"euad205","DOI":"10.1093\/europace\/euad205","volume":"25","author":"S Six","year":"2023","unstructured":"Six, S. et al. Patient-reported outcome measures on mental health and psychosocial factors in patients with Brugada syndrome. Europace 25, euad205 (2023).","journal-title":"Europace"},{"key":"622_CR143","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1001\/archinte.167.20.2226","volume":"167","author":"R Passman","year":"2007","unstructured":"Passman, R. et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch. Intern. Med. 167, 2226\u20132232 (2007).","journal-title":"Arch. Intern. Med."},{"key":"622_CR144","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1093\/eurheartj\/ehaa383","volume":"41","author":"D Chatterjee","year":"2020","unstructured":"Chatterjee, D. et al. An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins. Eur. Heart J. 41, 2878\u20132890 (2020).","journal-title":"Eur. Heart J."},{"key":"622_CR145","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/eurheartj\/ehaa468","volume":"41","author":"AAM Wilde","year":"2020","unstructured":"Wilde, A. A. M. & Lodder, E. M. A highly specific biomarker for Brugada syndrome. Also too good to be true? Eur. Heart J. 41, 2891\u20132893 (2020).","journal-title":"Eur. Heart J."},{"key":"622_CR146","first-page":"pgad327","volume":"2","author":"L Melo","year":"2023","unstructured":"Melo, L. et al. Deep learning unmasks the ECG signature of Brugada syndrome. Proc. Natl Acad. Sci. USA Nexus 2, pgad327 (2023).","journal-title":"Proc. Natl Acad. Sci. USA Nexus"},{"key":"622_CR147","doi-asserted-by":"publisher","first-page":"euad334","DOI":"10.1093\/europace\/euad334","volume":"25","author":"B Zanchi","year":"2023","unstructured":"Zanchi, B. et al. Identification of Brugada syndrome based on P-wave features: an artificial intelligence-based approach. Europace 25, euad334 (2023).","journal-title":"Europace"},{"key":"622_CR148","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1253\/circj.CJ-22-0792","volume":"87","author":"G Tse","year":"2023","unstructured":"Tse, G., Lee, S. & Liu, T. Prediction of the presence of ventricular fibrillation from a Brugada electrocardiogram using artificial intelligence. Circ. J. 87, 1015 (2023).","journal-title":"Circ. J."}],"container-title":["Nature Reviews Disease Primers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00622-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00622-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T07:02:14Z","timestamp":1748502134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41572-025-00622-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1038\/s41572-025-00622-5","relation":{},"ISSN":["2056-676X"],"issn-type":[{"value":"2056-676X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"25 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.K. is the founder of HumanX, a company that focuses on artificial intelligence in precision medicine and innovation in health care; he declares that his affiliation with HumanX is not a competing interest. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}